10760
MCLENA-1: A Phase II Trial of Lenalidomide in Mild Cognitive Impairment: Preliminary Data on Plasma Inflammatory Markers
Boris Decourt, Jeffrey R. Wilson, Liliana Dumitrescu, Katia Azarfar, Ellie M. Reyna, Jessica M. Kennedy, Marwan N. Sabbagh
Barrow Neurological Institute, Phoenix, AZ, USA, Texas Tech University Health Sciences Center, Lubbock, TX, USA, Arizona State University, Tempe, AZ, USA, Cleveland Clinic Lou Ruvo Center for Brain Health, Las...
Poster Presenter: Boris DeCourt
